Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.

DS, Kim; MJ, Kim; SH, Cha; HM, Kim; JH, Kim; KN, Kim; JS, Lee; JY, Choi; VB, Castells; HS, Kim; J, Bang; P, Oster

doi:10.1016/j.ijid.2016.02.010

Public

Safety and immunogenicity of a single dose of a quadrivalent meningococcal conjugate vaccine (MenACYW-D): a multicenter, blind-observer, randomized, phase III clinical trial in the Republic of Korea.

Shared by NobleBlocks on Feb 24, 2016 • 12:00 AM UTC

Authors:

Kim DS

Kim MJ

Cha SH

Abstract

<h4>Objectives</h4>To assess the safety and immunogenicity of a meningococcal polysaccharide diphtheria toxoid conjugate vaccine (MenACYW-D) in a Korean population.<h4>Methods</h4>This was a phase III, blind-observer, controlled study in which participants aged 11-55 years were randomized (2:1 ratio...

Subject

Safety

Immunogenicity

Meningococcal Vaccine

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!